Recombinant Expression Validates De Novo Sequencing Accuracy: Trastuzumab & Anti-Factor XII Case Study
Husseini, I.3, Ruiz, A.3, Mitchell, M.1, Wenzel, R.2, Nazabal, A.3, Feldman, H.M.1 1Green Mountain Antibodies, Burlington, VT 05401 2 CovalX Analytics Inc., Woburn, MA 01801 3 CovalX Analytics SA, Martillac, France 33650 Introduction In this case study, we evaluated the accuracy and functionality of sequences derived from two reference antibodies: anti-HER2 (trastuzumab) and anti–Factor XII […]
Read More